T1	PROC 61 94	prueba molecular de microbiología
T2	PROC 103 114	diagnóstico
#1	AnnotatorNotes T2	C0011900; Diagnosis; Diagnostic Procedure
T3	DISO 133 141	neumonía
#2	AnnotatorNotes T3	C0032285; Pneumonia; Disease or Syndrome
T4	PROC 190 304	ENSAYO CLÍNICO DE FASE IV, CON ASIGNACIÓN ALEATORIA, CONTROLADO, ABIERTO Y MULTICÉNTRICO, CON DOS GRUPOS PARALELOS
T5	PROC 311 344	EVALUAR EL IMPACTO DE LA EFICACIA
T6	PROC 352 371	PRUEBAS MOLECULARES
#3	AnnotatorNotes T6	C0752096; Molecular Diagnostic Testing; Laboratory Procedure | C0949688; Molecular Diagnostic Techniques; Molecular Biology Research Technique
T7	PROC 951 975	consentimiento informado
#4	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	PROC 496 510	hospitalizados
#5	AnnotatorNotes T8	C0019993; Hospitalization; Health Care Activity
T9	DISO 519 553	Neumonía adquirida en la comunidad
#6	AnnotatorNotes T9	C0694549; Community acquired pneumonia; Disease or Syndrome
T10	DISO 555 558	NAC
#7	AnnotatorNotes T10	C0694549; Community acquired pneumonia; Disease or Syndrome
T11	DISO 586 620	Neumonía adquirida en la comunidad
#8	AnnotatorNotes T11	C0694549; Community acquired pneumonia; Disease or Syndrome
T12	DISO 622 625	NAC
#9	AnnotatorNotes T12	C0694549; Community acquired pneumonia; Disease or Syndrome
T13	PROC 706 720	hospitalizados
#10	AnnotatorNotes T13	C0019993; Hospitalization; Health Care Activity
T14	PROC 725 736	diagnóstico
#11	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 740 743	NAC
#12	AnnotatorNotes T15	C0694549; Community acquired pneumonia; Disease or Syndrome
T16	DISO 878 889	incapacidad
#13	AnnotatorNotes T16	C0231172; handicapping condition; Finding
T17	DISO 1043 1059	Inmunodeprimidos
#14	AnnotatorNotes T17	C0085393; Immunocompromised Host; Finding
T18	PROC 1072 1085	quimioterapia
#15	AnnotatorNotes T18	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T19	PROC 1088 1100	radioterapia
#16	AnnotatorNotes T19	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T20	CHEM 1132 1157	fármacos inmunosupresores
#17	AnnotatorNotes T20	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T21	CHEM 1174 1185	corticoides
#18	AnnotatorNotes T21	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T22	PROC 1245 1287	trasplante de progenitores hematopoyéticos
#19	AnnotatorNotes T22	C0472699; Hemopoietic stem cell transplant; Therapeutic or Preventive Procedure
T23	DISO 1328 1331	HIV
T24	PROC 1289 1316	trasplante de órgano sólido
#20	AnnotatorNotes T24	C0730400; Solid organ transplant; Therapeutic or Preventive Procedure
T25	ANAT 1357 1361	céls
T26	PROC 1336 1339	CD4
#21	AnnotatorNotes T26	C0243009; CD4+ Lymphocyte Count; Laboratory Procedure
T27	DISO 1421 1454	Insuficiencia cardíaca congestiva
#22	AnnotatorNotes T27	C0018802; Congestive heart failure; Disease or Syndrome
T28	PROC 1505 1519	ensayo clínico
#23	AnnotatorNotes T28	C0008976; Clinical Trials; Research Activity
T29	PROC 1523 1534	tratamiento
#24	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	CHEM 155 167	antibióticos
#25	AnnotatorNotes T30	C0003232; Antibiotics; Antibiotic
T31	PROC 396 410	ANTIBIOTERAPIA
T32	ANAT 1259 1287	progenitores hematopoyéticos
#26	AnnotatorNotes T32	C0018956; Hematopoietic stem cells; Cell
T33	ANAT 1303 1316	órgano sólido
T34	ANAT 1435 1443	cardíaca
#27	AnnotatorNotes T34	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T35	DISO 417 451	NEUMONIA ADQUIRIDA EN LA COMUNIDAD
#28	AnnotatorNotes T35	C0694549; Community acquired pneumonia; Disease or Syndrome
T36	Date 13 17	2018
T37	LIVB 486 495	Pacientes
#29	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T39	LIVB 655 672	Pacientes adultos
#30	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T40	Age 674 687	18 años o más
T41	Duration 752 773	las primeras 24 horas
T42	LIVB 808 814	sujeto
#31	AnnotatorNotes T42	C0681850; Study Subject; Group
T43	LIVB 820 839	representante legal
#32	AnnotatorNotes T43	C4288823; Legal Representative for the Study; Human
T44	LIVB 845 853	familiar
#33	AnnotatorNotes T44	C0080103; Relative (related person); Family Group
T46	LIVB 894 900	sujeto
#34	AnnotatorNotes T46	C0681850; Study Subject; Group
T47	LIVB 1008 1015	mujeres
#35	AnnotatorNotes T47	C0043210; Woman; Population Group
T48	PHYS 1017 1025	embarazo
#36	AnnotatorNotes T48	C0032961; Pregnancy; Organism Function
T49	PHYS 1030 1039	lactancia
#37	AnnotatorNotes T49	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T50	Duration 1104 1123	los 90 días previos
T51	Duration 1163 1170	crónico
#38	AnnotatorNotes T51	C0205191; chronic; Temporal Concept
T52	Dose 1191 1212	dosis mínima de 15 mg
T54	Frequency 1212 1216	/día
T55	Duration 1220 1243	las últimas dos semanas
T56	LIVB 1318 1327	pacientes
#39	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T58	Duration 1409 1416	≤ a 24h
T59	LIVB 442 451	COMUNIDAD
#40	AnnotatorNotes T59	C0009462; Community; Group
T60	LIVB 544 553	comunidad
#41	AnnotatorNotes T60	C0009462; Community; Group
T61	LIVB 611 620	comunidad
#42	AnnotatorNotes T61	C0009462; Community; Group
T63	PHYS 1272 1287	hematopoyéticos
#43	AnnotatorNotes T63	C0018951; Hematopoiesis; Organ or Tissue Function
T38	PROC 1474 1478	NYHA
#44	AnnotatorNotes T38	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T45	LIVB 693 704	ambos sexos
#45	AnnotatorNotes T45	C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T57	DISO 1371 1377	Muerte
#46	AnnotatorNotes T57	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
A1	Population_data T39 Age
A2	Status T18 History_of
A3	Status T19 History_of
A4	Status T22 History_of
A5	Status T24 History_of
#47	AnnotatorNotes T4	C0282462; Phase 4 Clinical Trials; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity + C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity + C2826345; Parallel Study; Research Activity 
#49	AnnotatorNotes T23	C0458074; Human immunodeficiency virus (HIV) status; Finding
#50	AnnotatorNotes T25	C0007634; Cells; Cell | C1269647; Entire cell; Cell
#48	AnnotatorNotes T33	C0440790;  Solid organ; Body Part, Organ, or Organ Component
T53	Observation 1371 1387	Muerte inminente
#51	AnnotatorNotes T53	C2363727; Death imminent; Finding
T62	CONC 1389 1408	expectativa de vida
#52	AnnotatorNotes T62	C0023671; Life Expectancy; Group Attribute
R1	Has_Duration_or_Interval Arg1:T62 Arg2:T58	
R3	Overlap Arg1:T57 Arg2:T58	
R4	Location_of Arg1:T34 Arg2:T27	
T64	Result_or_Value 1456 1467	clase 3 o 4
R5	Has_Result_or_Value Arg1:T38 Arg2:T64	
T65	Observation 1483 1519	Participación en otro ensayo clínico
R7	Before Arg1:T1 Arg2:T2	
R9	Overlap Arg1:T6 Arg2:T31	
R10	Experiences Arg1:T37 Arg2:T8	
R13	Experiences Arg1:T37 Arg2:T9	
R14	Experiences Arg1:T37 Arg2:T10	
R15	Has_Age Arg1:T39 Arg2:T40	
R16	Has_Age Arg1:T45 Arg2:T40	
R17	Experiences Arg1:T39 Arg2:T13	
R18	Experiences Arg1:T45 Arg2:T13	
R19	Experiences Arg1:T45 Arg2:T15	
R20	Experiences Arg1:T39 Arg2:T15	
R22	Overlap Arg1:T15 Arg2:T41	
R23	Experiences Arg1:T46 Arg2:T16	
R24	Experiences Arg1:T47 Arg2:T48	
R25	Experiences Arg1:T47 Arg2:T49	
T66	Quantifier_or_Qualifier 1060 1066	graves
#53	AnnotatorNotes T66	C1547227; Severe - Severity of Illness Code; Intellectual Product
R26	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T66	
R27	Overlap Arg1:T19 Arg2:T50	
R28	Overlap Arg1:T18 Arg2:T50	
R29	Causes Arg1:T18 Arg2:T17	
R30	Causes Arg1:T19 Arg2:T17	
R31	Causes Arg1:T20 Arg2:T17	
R32	Causes Arg1:T21 Arg2:T17	
R33	Has_Duration_or_Interval Arg1:T21 Arg2:T51	
R34	Has_Dose_or_Strength Arg1:T21 Arg2:T52	
R35	Has_Frequency Arg1:T21 Arg2:T54	
R36	Has_Duration_or_Interval Arg1:T21 Arg2:T55	
R38	Used_for Arg1:T32 Arg2:T22	
R39	Causes Arg1:T22 Arg2:T17	
R40	Causes Arg1:T24 Arg2:T17	
R41	Used_for Arg1:T33 Arg2:T24	
R42	Experiences Arg1:T56 Arg2:T23	
R43	Experiences Arg1:T56 Arg2:T17	
T67	Result_or_Value 1340 1365	inferiores a 200 céls/mm3
R44	Has_Result_or_Value Arg1:T26 Arg2:T67	
R45	Experiences Arg1:T56 Arg2:T26	
R46	Overlap Arg1:T23 Arg2:T26	
R47	Overlap Arg1:T17 Arg2:T23	
T68	Observation 905 937	gravedad de la situación clínica
R49	Experiences Arg1:T46 Arg2:T68	
R50	Causes Arg1:T68 Arg2:T16	
#54	AnnotatorNotes T31	C0338237; Antibiotic therapy; Therapeutic or Preventive Procedure
#55	AnnotatorNotes T1	C0752096; Molecular Diagnostic Testing; Laboratory Procedure | C0949688; Molecular Diagnostic Techniques; Molecular Biology Research Technique
A6	Experiencer T56 Patient
A7	Status T57 Future
A8	Assertion T16 Hypothetical
A9	Experiencer T46 Patient
A10	Assertion T68 Hypothetical
A11	Experiencer T45 Patient
A12	Experiencer T39 Patient
A13	Experiencer T61 Other
A14	Experiencer T44 Family_member
A15	Experiencer T43 Other
A16	Experiencer T42 Patient
A17	Experiencer T60 Other
A18	Experiencer T59 Other
A19	Experiencer T37 Patient
A20	Experiencer T47 Patient
